Diabetech - Diabetes Tech, Research, News

Gary Scheiner, a certified diabetes care and education specialist and founder of Integrated Diabetes Services, shares his expertise on optimizing basal insulin for better glucose stability. He explains the critical role of basal insulin in managing liver glucose and how incorrect settings can lead to highs and lows. Listeners learn about common misconceptions, the effects of various factors on basal needs, and practical tips for testing and adjusting insulin. Gary also highlights the advantages of advanced diabetes technology like pumps and automated systems.

2025 delivered major innovations in diabetes tech as well as surprising twists and today we explore the wins, the fails, and what these trends mean for people living with diabetes. I sit down with Kamil Armacky of Nerdabetic to unpack everything from Libre 3 Plus expanding pump integrations, updates and sensor recall, to Dexcom’s new 15-day sensor and how the community feels about it. We also dive into major industry shifts, including Medtronic Diabetes separating to form MiniMed, Omnipod’s roadmap for Omnipod 6 and beyond, and Eversense taking full control of its implantable business. This is a big one!   Learn about Omnipod 5 (today's sponsor)*   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

In this conversation, Pablo Medina, a medical graduate and software engineer diagnosed with LADA, shares his journey from misdiagnosis to innovation. He created an iPhone app to track insulin patch usage after struggling with existing diabetes tech. Pablo discusses his experiences with devices like InPen and Omnipod 5, highlighting the gaps he encountered. He reveals the challenges of app development and advocates for better CGM interoperability. His story is a testament to how patient-driven solutions can shape diabetes technology.

Laura Endres, Senior VP at Medtronic Diabetes, shares exciting insights about the new Instinct CGM. This 15-day, no-calibration sensor integrates seamlessly with the 780G insulin pump and highlights Medtronic's partnership with Abbott. Laura offers a live demo, showcasing its user-friendly applicator. She compares Instinct with Simplera, discusses future pump innovations, and emphasizes the importance of customer choice in sensor technology. Plus, get a glimpse of upcoming features like customizable alerts and global rollout plans!

On our new show Optimizing Diabetes Tech (ODT) my co-host Gary Scheiner CDCES and I discuss how people with diabetes can take full advantage of their continuous glucose monitors to make managing Diabetes easier and safer. We get into how to react to alarms, adjust settings, and the features you need to know about. We also answer your questions about CGMs.   Learn about Omnipod 5 (today's sponsor)*   Learn About Integrated Diabetes Services (Gary’s Practice)   Send us YOUR questions!   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

This week, cybersecurity expert Josiah Dykstra shares insights from his career at the NSA and his life with type 1 diabetes. He discusses the stringent security measures around medical devices in classified settings and why standalone devices, like Dexcom receivers, are crucial. Josiah opens up about his initial fears of pump hacking, his decision to embrace automated insulin delivery, and the FDA's evolving regulations on medical tech. He emphasizes the importance of personal cybersecurity and urges patients to advocate for stronger security measures.

Dr. David Ahn, chief of diabetes services at the Mary and Dick Allen Diabetes Center, explores the future of insulin pumps. He discusses the competitive landscape between companies like Omnipod and Tandem, the importance of seven-day wearable infusion sets, and the evolving algorithms for insulin delivery. Ahn highlights the potential for dual-hormone systems and addresses the future of closed-loop systems. The conversation delves into innovations like Beta Bionics' reusable Mint pump and the need for more user-friendly technology in diabetes management.

I sit down with Breakthrough T1D CEO Dr. Aaron Kowalski to trace his journey—from open-source roots and the early CGM days to leading one of the most influential organizations in diabetes. We dig into how the Artificial Pancreas Project helped make CGMs and AID systems mainstream, and why Aaron believes he’ll one day take off his insulin pump. He breaks down today’s cure pathways—cell replacement and regeneration, immune modulation, and prevention—plus Project ACT to accelerate cell therapies. We also cover the stages of type 1 diabetes and the latest on teplizumab, alongside the push for dynamic algorithms and smarter insulins.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Pregnancy with diabetes can feel overwhelming—and our healthcare system doesn’t always provide the support people need. In this episode, I talk with Kari Cao and Kelly Carter from RenewRx, a platform transforming prenatal care with behavior-based coaching, CGM insights, and real-time support for both patients and providers. It’s a heartwarming conversation about how they’re filling the gaps in our healthcare system and empowering women through one of the most important journeys of their lives.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Researchers are pushing the boundaries of noninvasive glucose monitoring—by looking to the brain. In this episode, I speak with Dr. Casey Halpern, founder and CEO of SynchNeuro, a startup developing a small wearable that sits behind the ear and reads brainwave activity (EEG) to track glucose levels. The device interprets electrical signals from the hypothalamus and other brain regions to detect shifts in glucose, stress, and metabolism in real time. Early testing suggests accuracy close to today’s CGMs—but without the needle. Dr. Halpern shares how this technology works, what’s next in development, and why brain-based monitoring could redefine the future of wearable health tech.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.